1. Home
  2. APLS vs PSNY Comparison

APLS vs PSNY Comparison

Compare APLS & PSNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLS
  • PSNY
  • Stock Information
  • Founded
  • APLS 2009
  • PSNY 2017
  • Country
  • APLS United States
  • PSNY Sweden
  • Employees
  • APLS N/A
  • PSNY N/A
  • Industry
  • APLS Biotechnology: Pharmaceutical Preparations
  • PSNY Auto Manufacturing
  • Sector
  • APLS Health Care
  • PSNY Consumer Discretionary
  • Exchange
  • APLS Nasdaq
  • PSNY Nasdaq
  • Market Cap
  • APLS 2.2B
  • PSNY 2.4B
  • IPO Year
  • APLS 2017
  • PSNY N/A
  • Fundamental
  • Price
  • APLS $16.93
  • PSNY $1.10
  • Analyst Decision
  • APLS Buy
  • PSNY Hold
  • Analyst Count
  • APLS 19
  • PSNY 6
  • Target Price
  • APLS $37.50
  • PSNY $1.21
  • AVG Volume (30 Days)
  • APLS 2.9M
  • PSNY 4.8M
  • Earning Date
  • APLS 05-07-2025
  • PSNY 05-12-2025
  • Dividend Yield
  • APLS N/A
  • PSNY N/A
  • EPS Growth
  • APLS N/A
  • PSNY N/A
  • EPS
  • APLS N/A
  • PSNY N/A
  • Revenue
  • APLS $775,839,000.00
  • PSNY $2,034,261,000.00
  • Revenue This Year
  • APLS $1.54
  • PSNY $109.56
  • Revenue Next Year
  • APLS $22.80
  • PSNY $53.60
  • P/E Ratio
  • APLS N/A
  • PSNY N/A
  • Revenue Growth
  • APLS 48.04
  • PSNY N/A
  • 52 Week Low
  • APLS $16.10
  • PSNY $0.61
  • 52 Week High
  • APLS $43.76
  • PSNY $1.94
  • Technical
  • Relative Strength Index (RSI)
  • APLS 41.44
  • PSNY 50.70
  • Support Level
  • APLS $16.61
  • PSNY $1.00
  • Resistance Level
  • APLS $17.48
  • PSNY $1.18
  • Average True Range (ATR)
  • APLS 0.86
  • PSNY 0.07
  • MACD
  • APLS 0.09
  • PSNY -0.01
  • Stochastic Oscillator
  • APLS 28.47
  • PSNY 47.87

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

About PSNY Polestar Automotive Holding UK PLC ADS

Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars, namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from the United Kingdom.

Share on Social Networks: